At Ginkgo we're building a high-throughput process for the engineering of mammalian cell genomes, enabling a wide range of industrial and pharmaceutical applications. Making biology easier to engineer means we also have to make biology safer to engineer, too. We're helping to develop software, diagnostics, vaccines, and other therapeutics against emerging threats and challenges, like COVID-19.
